Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

Market Cap	22.02B
Revenue (ttm)	8.11B
Net Income (ttm)	148.47M
Shares Out	1.67B
EPS (ttm)	0.09
PE Ratio	148.30
Forward PE	16.16
Dividend	0.30 (2.26%)
Ex-Dividend Date	Jul 19, 2024

Volume	15,246,324
Average Volume	13,237,561
Open	13.30
Previous Close	13.18
Day's Range	13.30 - 13.57
52-Week Range	12.41 - 20.08
Beta	0.77
RSI	39.32
Earnings Date	Apr 29, 2025

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for respiratory health, cardiovascular disease, diabetes mellitus, oncology, urologic disease, sleep-improving, and anti-aging. The company also provides dietary supplements, health food and drinks, disinfection products, and personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 13,958
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002603

Financial Performance

In 2023, SHE:002603's revenue was 10.32 billion, a decrease of -17.67% compared to the previous year's 12.53 billion. Earnings were 1.35 billion, a decrease of -42.76%.